Skip to main content

Edwards Lifesciences entry-level jobs & internships

Open roles at Edwards Lifesciences

10 open roles in the US

Entry Level Assembler

Edwards Lifesciences · Salt Lake City, UT

  • Entry level

$38k /yr

2 weeks ago

Engineering Internship

Edwards Lifesciences · Irvine, CA +1 more

  • Internship
  • Summer 2027

$54k – $72k /yr

2 weeks ago

Engineering Co-Op Program

Edwards Lifesciences · Irvine, CA +1 more

  • Internship
  • Spring 2027

$54k – $72k /yr

2 weeks ago

Clinical & Regulatory Internship

Edwards Lifesciences · Irvine, CA

  • Internship
  • Summer 2027

$54k – $72k /yr

2 weeks ago

Supply Chain Internship

Edwards Lifesciences · Draper, UT +1 more

  • Internship
  • Summer 2027

Pay not listed

2 weeks ago

Supply Chain Internship

Edwards Lifesciences · Irvine, CA

  • Internship
  • Summer 2027

$54k – $72k /yr

2 weeks ago

Entry Level Assembler

Edwards Lifesciences · Salt Lake City, UT

  • Entry level

$38k – $42k /yr

2 weeks ago

Entry Level Machine Operator

Edwards Lifesciences · Salt Lake City, UT

  • Entry level
  • 0–2 years

$38k – $42k /yr

2 weeks ago

Quality Engineer I, NPD

Edwards Lifesciences · Salt Lake City, UT

  • Entry level
  • 0–2 years

$70k – $90k /yr

2 weeks ago

About Edwards Lifesciences

Edwards Lifesciences is a global leader in patient-focused innovations for structural heart disease, critical care, and surgical monitoring. Founded in 1958 and headquartered in Irvine, California, USA, the company is renowned for pioneering heart valve therapies and advanced hemodynamic monitoring solutions. With a mission to improve and enhance the quality of life for patients, Edwards Lifesciences develops products that address complex cardiovascular conditions and enable clinicians to deliver optimal care.

The company employs over 17,000 people worldwide and operates in more than 100 countries, maintaining a strong reputation for clinical excellence, technological innovation, and ethical business practices. Edwards Lifesciences is publicly traded on the NYSE under the ticker symbol EW and has consistently demonstrated leadership in the structural heart market, particularly in transcatheter aortic valve replacement (TAVR) technology. In recent years, the company has expanded its portfolio with new minimally invasive therapies and has been recognized for its sustainability initiatives and philanthropic efforts through the Edwards Lifesciences Foundation.